ml 7 has been researched along with Breast Neoplasms in 2 studies
ML-7 : An N-sulfonyldiazepane resullting from the formal condensation of 5-iodo-1-naphthylsulfonic acid with one of the nitrogens of 1,4-diazepane. It is a selective inhibitor of myosin light chain kinase (EC 2.7.11.18).
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, B | 1 |
| Yan, Y | 1 |
| Zhou, J | 1 |
| Zhou, Q | 1 |
| Gui, S | 1 |
| Wang, Y | 1 |
| Zhou, X | 1 |
| Liu, Y | 1 |
| You, J | 1 |
| Zhang, H | 1 |
| Zhang, X | 1 |
| Ye, L | 1 |
2 other studies available for ml 7 and Breast Neoplasms
| Article | Year |
|---|---|
A novel all-trans retinoid acid derivatives inhibits the migration of breast cancer cell lines MDA-MB-231 via myosin light chain kinase involving p38-MAPK pathway.
Topics: Antineoplastic Agents; Azepines; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Movemen | 2013 |
Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2.
Topics: Azepines; beta Catenin; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cycli | 2008 |